Andrew Witty has spent several years talking about his efforts to clean up the aggressive marketing tactics he inherited as GlaxoSmithKline's chief executive. Now he faces the uncomfortable problem of defending the company against bribery allegations in China that occurred on his watch.
via WSJ.com: US Business http://online.wsj.com/article/SB10001424127887323997004578640142259791244.html?mod=pls_whats_news_us_business_f
via WSJ.com: US Business http://online.wsj.com/article/SB10001424127887323997004578640142259791244.html?mod=pls_whats_news_us_business_f
Nessun commento:
Posta un commento